BACE1 Gene Promoter Single-Nucleotide Polymorphisms in Alzheimer’s Disease
暂无分享,去创建一个
[1] Guiliang Tang,et al. The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 , 2008, The Journal of Neuroscience.
[2] R. Tanzi,et al. Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity , 2007, Neuron.
[3] A. Delacourte,et al. Involvement of β-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity , 2007, Proceedings of the National Academy of Sciences.
[4] Hong Qing,et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression , 2006, Proceedings of the National Academy of Sciences.
[5] Xiulian Sun,et al. BACE2, as a novel APP θ‐secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] Weihui Zhou,et al. Leaky Scanning and Reinitiation Regulate BACE1 Gene Expression , 2006, Alzheimer's & Dementia.
[7] Y. Li,et al. The FASEB Journal • Research Communication Control of APP processing and A � generation level by , 2022 .
[8] Bosheng Zhang,et al. Genetic studies of A2M and BACE1 genes in Chinese Han Alzheimer's disease patients , 2005, Neuroreport.
[9] B. Hyman,et al. The Low Density Lipoprotein Receptor-related Protein (LRP) Is a Novel β-Secretase (BACE1) Substrate* , 2005, Journal of Biological Chemistry.
[10] H. Qing,et al. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] H. Qing,et al. Oxidative stress potentiates BACE1 gene expression and Aβ generation , 2005, Journal of Neural Transmission.
[12] G. Westmeyer,et al. Dimerization of β-Site β-Amyloid Precursor Protein-cleaving Enzyme* , 2004, Journal of Biological Chemistry.
[13] H. Qing,et al. Degradation of BACE by the ubiquitin‐proteasome pathway , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] T. Bayer,et al. Human BACE Forms Dimers and Colocalizes with APP* , 2004, Journal of Biological Chemistry.
[15] R. Yan,et al. Reticulon family members modulate BACE1 activity and amyloid-β peptide generation , 2004, Nature Medicine.
[16] Bryan Maloney,et al. Functional characterization of the 5′ flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] C. Haass,et al. Expression of the Alzheimer protease BACE1 is suppressed via its 5'‐untranslated region , 2004, EMBO reports.
[18] Yan-Hui Liu,et al. Crystallization of glycosylated human BACE protease domain expressed in Trichoplusia ni. , 2004, Biochimica et biophysica acta.
[19] J. Buxbaum,et al. BACE (β-secretase) modulates the processing of APLP2 in vivo , 2004, Molecular and Cellular Neuroscience.
[20] T. Südhof,et al. Cleavage of Amyloid-β Precursor Protein and Amyloid-β Precursor-like Protein by BACE 1* , 2004, Journal of Biological Chemistry.
[21] G. Edelman,et al. Differential utilization of upstream AUGs in the beta-secretase mRNA suggests that a shunting mechanism regulates translation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] Marija Mihailovich,et al. Translational regulation of BACE-1 expression in neuronal and non-neuronal cells. , 2004, Nucleic acids research.
[23] D. Saur,et al. Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[24] B. Hyman,et al. Beta-secretase activity increases with aging in human, monkey, and mouse brain. , 2004, The American journal of pathology.
[25] Hong Qing,et al. Transcriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1 , 2004, Molecular and Cellular Biology.
[26] B. de Strooper,et al. The Cell Adhesion Protein P-selectin Glycoprotein Ligand-1 Is a Substrate for the Aspartyl Protease BACE1* , 2003, Journal of Biological Chemistry.
[27] D. Comas,et al. Association study between Alzheimer’s disease and genes involved in Aβ biosynthesis, aggregation and degradation: suggestive results with BACE1 , 2003, Journal of Neurology.
[28] W. Maier,et al. Polymorphism in the BACE gene influences the risk for Alzheimer's disease , 2003, Neuroreport.
[29] S. Antonarakis,et al. Specific BACE1 genotypes provide additional risk for late‐onset alzheimer disease in APOE ε4 carriers , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[30] R. Doms,et al. Endoproteolysis of β-Secretase (β-Site Amyloid Precursor Protein-cleaving Enzyme) within Its Catalytic Domain , 2003, The Journal of Biological Chemistry.
[31] J. Knight,et al. Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation. , 2003, Clinical science.
[32] B. Hyman,et al. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. , 2002, Archives of neurology.
[33] C. Masters,et al. Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease , 2002 .
[34] D. Praticò. Alzheimer's disease and oxygen radicals: new insights. , 2002, Biochemical pharmacology.
[35] S. Kitazume,et al. Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[36] C. Duijn,et al. Amyloid β secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease , 2001, Neuroscience Letters.
[37] M. Cruts,et al. Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease. , 2001, Neuroscience letters.
[38] E. Rogaev,et al. Mutations in the open reading frame of the β-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease , 2001, Neurogenetics.
[39] A. Nunomura,et al. Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.
[40] J. Morris,et al. Association studies using novel polymorphisms in BACE1 and BACE2 , 2001, Neuroreport.
[41] I. Kola,et al. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. , 2001, Human molecular genetics.
[42] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[43] D. Easton,et al. The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease , 2001, Neuroreport.
[44] N. Seidah,et al. Coordinated Expression of β‐Amyloid Precursor Protein and the Putative β‐Secretase BACE and α‐Secretase ADAM10 in Mouse and Human Brain , 2000 .
[45] F. Acquati,et al. The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the Down critical region , 2000, FEBS letters.
[46] J. Tang,et al. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[47] Alfredo G. Tomasselli,et al. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.
[48] R. Barbour,et al. Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.
[49] David G. Tew,et al. Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.
[50] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[51] P. Green,et al. Consed: a graphical tool for sequence finishing. , 1998, Genome research.
[52] P. Green,et al. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. , 1998, Genome research.
[53] D. Blacker,et al. The genetics of Alzheimer disease: current status and future prospects. , 1998, Archives of neurology.
[54] S. Younkin,et al. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.
[55] D. Selkoe,et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.
[56] R. Tanzi,et al. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. , 2007, Neuron.
[57] Hong Qing,et al. Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. , 2004, Molecular and cellular biology.
[58] T. Südhof,et al. Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1. , 2004, The Journal of biological chemistry.
[59] Tao Li,et al. The 1239G/C polymorphism in exon 5 of BACE1 gene may be associated with sporadic Alzheimer's disease in Chinese Hans , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[60] J. Buxbaum,et al. BACE (beta-secretase) modulates the processing of APLP2 in vivo. , 2004, Molecular and cellular neurosciences.
[61] G. Westmeyer,et al. Dimerization of beta-site beta-amyloid precursor protein-cleaving enzyme. , 2004, The Journal of biological chemistry.
[62] P. Wong,et al. Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease , 2003, Nature Medicine.
[63] R. Doms,et al. Endoproteolysis of beta-secretase (beta-site amyloid precursor protein-cleaving enzyme) within its catalytic domain. A potential mechanism for regulation. , 2003, The Journal of biological chemistry.
[64] C. Masters,et al. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. , 2002, Annals of neurology.
[65] W. Richards,et al. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. , 2001, Nature neuroscience.
[66] H. Cai,et al. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. , 2001, Nature neuroscience.
[67] S. Kitazume,et al. Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[68] N. Seidah,et al. Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. , 2000, Journal of neurochemistry.
[69] C. Southan,et al. Identification of a novel aspartic protease (Asp 2) as beta-secretase. , 1999, Molecular and cellular neurosciences.
[70] D. Selkoe,et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. , 1992, Nature.
[71] A. Levine,et al. A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans , 2004, Cell.